Correlation Between ZyVersa Therapeutics and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Cullinan Oncology LLC, you can compare the effects of market volatilities on ZyVersa Therapeutics and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Cullinan Oncology.
Diversification Opportunities for ZyVersa Therapeutics and Cullinan Oncology
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between ZyVersa and Cullinan is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Cullinan Oncology go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Cullinan Oncology
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to generate 1.21 times more return on investment than Cullinan Oncology. However, ZyVersa Therapeutics is 1.21 times more volatile than Cullinan Oncology LLC. It trades about -0.23 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.32 per unit of risk. If you would invest 141.00 in ZyVersa Therapeutics on November 28, 2024 and sell it today you would lose (23.00) from holding ZyVersa Therapeutics or give up 16.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Cullinan Oncology LLC
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Cullinan Oncology LLC |
ZyVersa Therapeutics and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Cullinan Oncology
The main advantage of trading using opposite ZyVersa Therapeutics and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |